REGN
Price
$824.84
Change
+$1.46 (+0.18%)
Updated
Sep 22, 6:59 PM EST
44 days until earnings call
VRTX
Price
$349.53
Change
-$4.75 (-1.34%)
Updated
Sep 22, 6:59 PM EST
38 days until earnings call

Compare trend and price REGN vs VRTX

Header iconREGN vs VRTX Comparison
Open Charts REGN vs VRTXBanner chart's image
Regeneron Pharmaceuticals
Price$824.84
Change+$1.46 (+0.18%)
Volume$142.01K
CapitalizationN/A
Vertex Pharmaceuticals
Price$349.53
Change-$4.75 (-1.34%)
Volume$552.96K
CapitalizationN/A
View a ticker or compare two or three
REGN vs VRTX Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
REGN vs. VRTX commentary
Sep 24, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REGN is a Hold and VRTX is a StrongBuy.

COMPARISON
Comparison
Sep 24, 2023
Stock price -- (REGN: $824.84 vs. VRTX: $349.53)
Brand notoriety: REGN: Notable vs. VRTX: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: REGN: 90% vs. VRTX: 95%
Market capitalization -- REGN: $89.54B vs. VRTX: $90.21B
REGN [@Biotechnology] is valued at $89.54B. VRTX’s [@Biotechnology] market capitalization is $90.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $410.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

REGN’s FA Score shows that 2 FA rating(s) are green whileVRTX’s FA Score has 1 green FA rating(s).

  • REGN’s FA Score: 2 green, 3 red.
  • VRTX’s FA Score: 1 green, 4 red.
According to our system of comparison, both REGN and VRTX are a good buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

REGN’s TA Score shows that 3 TA indicator(s) are bullish while VRTX’s TA Score has 4 bullish TA indicator(s).

  • REGN’s TA Score: 3 bullish, 6 bearish.
  • VRTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, VRTX is a better buy in the short-term than REGN.

Price Growth

REGN (@Biotechnology) experienced а +0.17% price change this week, while VRTX (@Biotechnology) price change was +0.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.79%. For the same industry, the average monthly price growth was +32.38%, and the average quarterly price growth was +31.88%.

Reported Earning Dates

REGN is expected to report earnings on Nov 07, 2023.

VRTX is expected to report earnings on Nov 01, 2023.

Industries' Descriptions

@Biotechnology (-4.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for REGN with price predictions.
OPEN
A.I.dvisor published
a Summary for VRTX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
VRTX($90.2B) and REGN($89.5B) have the same market capitalization . VRTX has higher P/E ratio than REGN: VRTX (27.03) vs REGN (21.79). VRTX YTD gains are higher at: 21.037 vs. REGN (14.325). REGN has higher annual earnings (EBITDA): 5.24B vs. VRTX (4.51B). VRTX has more cash in the bank: 11.2B vs. REGN (8.93B). VRTX has less debt than REGN: VRTX (768M) vs REGN (2.7B). REGN has higher revenues than VRTX: REGN (12.7B) vs VRTX (9.51B).
REGNVRTXREGN / VRTX
Capitalization89.5B90.2B99%
EBITDA5.24B4.51B116%
Gain YTD14.32521.03768%
P/E Ratio21.7927.0381%
Revenue12.7B9.51B134%
Total Cash8.93B11.2B80%
Total Debt2.7B768M352%
FUNDAMENTALS RATINGS
REGN vs VRTX: Fundamental Ratings
REGN
VRTX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
76
Overvalued
PROFIT vs RISK RATING
1..100
715
SMR RATING
1..100
4940
PRICE GROWTH RATING
1..100
4846
P/E GROWTH RATING
1..100
1940
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

REGN's Valuation (76) in the Biotechnology industry is in the same range as VRTX (76). This means that REGN’s stock grew similarly to VRTX’s over the last 12 months.

REGN's Profit vs Risk Rating (7) in the Biotechnology industry is in the same range as VRTX (15). This means that REGN’s stock grew similarly to VRTX’s over the last 12 months.

VRTX's SMR Rating (40) in the Biotechnology industry is in the same range as REGN (49). This means that VRTX’s stock grew similarly to REGN’s over the last 12 months.

VRTX's Price Growth Rating (46) in the Biotechnology industry is in the same range as REGN (48). This means that VRTX’s stock grew similarly to REGN’s over the last 12 months.

REGN's P/E Growth Rating (19) in the Biotechnology industry is in the same range as VRTX (40). This means that REGN’s stock grew similarly to VRTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
REGNVRTX
RSI
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
57%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 3 days ago
56%
Momentum
ODDS (%)
Bearish Trend 3 days ago
57%
Bullish Trend 3 days ago
58%
MACD
ODDS (%)
Bearish Trend 3 days ago
62%
Bullish Trend 3 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
60%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 3 days ago
49%
Advances
ODDS (%)
Bullish Trend 6 days ago
64%
Bullish Trend 6 days ago
60%
Declines
ODDS (%)
Bearish Trend 4 days ago
54%
Bearish Trend 17 days ago
49%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
65%
Bearish Trend 3 days ago
44%
Aroon
ODDS (%)
Bullish Trend 3 days ago
73%
N/A
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FG28.861.68
+6.18%
F&G Annuities & Life
SPG111.680.04
+0.04%
Simon Property Group
BLFY8.40-0.06
-0.71%
Blue Foundry Bancorp
SPH14.68-0.15
-1.01%
Suburban Propane Partners L P
LGL4.67-0.05
-1.02%
LGL Group (The)

REGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, REGN has been loosely correlated with VRTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if REGN jumps, then VRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REGN
1D Price
Change %
REGN100%
+0.18%
VRTX - REGN
44%
Loosely correlated
-1.34%
INCY - REGN
39%
Loosely correlated
-1.21%
NKTX - REGN
38%
Loosely correlated
-6.40%
GBIO - REGN
38%
Loosely correlated
-4.06%
SRNEQ - REGN
36%
Loosely correlated
-2.54%
More

VRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRTX has been loosely correlated with REGN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if VRTX jumps, then REGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRTX
1D Price
Change %
VRTX100%
-1.34%
REGN - VRTX
43%
Loosely correlated
+0.18%
BMRN - VRTX
38%
Loosely correlated
+0.28%
GMAB - VRTX
38%
Loosely correlated
-1.12%
SRPT - VRTX
37%
Loosely correlated
+0.32%
INCY - VRTX
37%
Loosely correlated
-1.21%
More